325 results on '"Stallings VA"'
Search Results
2. Weights of parents and infants: Is there a relationship?
- Author
-
Stunkard, AJ, primary, Berkowitz, RI, additional, Stallings, VA, additional, and Cater, JR, additional
- Published
- 1999
- Full Text
- View/download PDF
3. Longitudinal changes in liver enzymes and growth status in children with cystic fibrosis
- Author
-
Mascarenhas, MR, primary, Zemel, BS, additional, Maller, ES, additional, Scanlin, F., additional, and Stallings, VA, additional
- Published
- 1998
- Full Text
- View/download PDF
4. Vertebral compression fractures in pediatric patients with Crohn's disease
- Author
-
Semeao, EJ, primary, Stallings, VA, additional, Peck, SN, additional, and Piccoli, DA, additional
- Published
- 1997
- Full Text
- View/download PDF
5. Energy expenditure of children and adolescents with severe disabilities: a cerebral palsy model
- Author
-
Stallings, VA, primary, Zemel, BS, additional, Davies, JC, additional, Cronk, CE, additional, and Charney, EB, additional
- Published
- 1996
- Full Text
- View/download PDF
6. Body composition of children with cystic fibrosis with mild clinical manifestations compared with normal children
- Author
-
Tomezsko, JL, primary, Scanlin, TF, additional, and Stallings, VA, additional
- Published
- 1994
- Full Text
- View/download PDF
7. Relation between dietary fat intake type and serum fatty acid status in children with cystic fibrosis.
- Author
-
Maqbool A, Schall JI, Gallagher PR, Zemel BS, Strandvik B, Stallings VA, Maqbool, Asim, Schall, Joan I, Gallagher, Paul R, Zemel, Babette S, Strandvik, Birgitta, and Stallings, Virginia A
- Published
- 2012
- Full Text
- View/download PDF
8. Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia
- Author
-
Vaisman, N, primary, Stallings, VA, additional, Chan, H, additional, Weitzman, SS, additional, Clarke, R, additional, and Pencharz, PB, additional
- Published
- 1993
- Full Text
- View/download PDF
9. Poor post-operative growth in infants with two-ventricle physiology.
- Author
-
Anderson JB, Marino BS, Irving SY, García-España JF, Ravishankar C, Stallings VA, Medoff-Cooper B, Anderson, Jeffrey B, Marino, Bradley S, Irving, Sharon Y, García-España, J Felipe, Ravishankar, Chitra, Stallings, Virginia A, and Medoff-Cooper, Barbara
- Published
- 2011
- Full Text
- View/download PDF
10. Clinical and genetic correlates of exercise performance in young children with cystic fibrosis.
- Author
-
McBride MG, Schall JI, Zemel BS, Stallings VA, Ittenbach RF, and Paridon SM
- Published
- 2010
- Full Text
- View/download PDF
11. Nutrition training in graduate medical (residency) education: a survey of selected training programs
- Author
-
Weinsier, RL, primary, Boker, JR, additional, Brooks, CM, additional, Kushner, RF, additional, Olson, AK, additional, Mark, DA, additional, St Jeor, ST, additional, Stallings, VA, additional, Winick, M, additional, and Heber, D, additional
- Published
- 1991
- Full Text
- View/download PDF
12. Update on fat-soluble vitamins in cystic fibrosis.
- Author
-
Maqbool A and Stallings VA
- Published
- 2008
- Full Text
- View/download PDF
13. Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis.
- Author
-
Maqbool A, Schall JI, Garcia-Espana JF, Zemel BS, Strandvik B, Stallings VA, Maqbool, Asim, Schall, Joan I, Garcia-Espana, J Felipe, Zemel, Babette S, Strandvik, Birgitta, and Stallings, Virginia A
- Published
- 2008
- Full Text
- View/download PDF
14. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation.
- Author
-
Rovner AJ, Stallings VA, Schall JI, Leonard MB, and Zemel BS
- Abstract
BACKGROUND: Cystic fibrosis (CF) with pancreatic insufficiency is associated with poor absorption of fat and fat-soluble vitamins, including vitamin D. Pancreatic enzyme supplementation does not completely correct fat malabsorption in CF patients. OBJECTIVE: The objective of the study was to compare the vitamin D status of children, adolescents, and young adults with CF who were treated with routine vitamin D and pancreatic enzyme supplements with the vitamin D status of a healthy reference group from a similar geographic area. DESIGN: Growth, dietary intake, and serum concentrations of 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)(2)D], and parathyroid hormone (PTH) were measured in 101 white subjects with CF and a reference group of 177 white subjects. RESULTS: The median daily vitamin D supplementation in the CF group was 800 IU. The mean +/- SD serum concentrations of 25(OH)D were 20.7 +/- 6.5 ng/mL in the CF group and 26.2 +/- 8.6 ng/mL in the reference group (P < 0.001). Vitamin D deficiency and insufficiency were defined as 25(OH)D concentrations < 11 ng/mL and < 30 ng/mL, respectively. Seven percent of the CF group and 2% of the healthy reference group were vitamin D deficient (P < 0.03). Ninety percent of the CF group and 74% of the healthy reference group were vitamin D insufficient (P < 0.01). Twenty-five percent of the CF group and 9% of the healthy reference group had elevated PTH (P < 0.006). The odds of vitamin D insufficiency in the CF group, compared with the healthy reference group, were 1.2 (95% CI: 1.1, 1.3) after adjustment for season and age. CONCLUSION: Despite daily vitamin D supplementation, serum 25(OH)D concentrations remain low in children, adolescents, and young adults with CF. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
15. Adolescent development and energy expenditure in females with cystic fibrosis.
- Author
-
Stallings VA, Tomezsko JL, Schall JI, Mascarenhas MR, Stettler N, Scanlin TF, and Zemel BS
- Abstract
Background & AimsPoor nutrition and growth status are common in people with cystic fibrosis (CF), and females often have a worse clinical course. Relationships between sexual maturity, nutrition, resting energy expenditure (REE), and pulmonary status in females with CF and pancreatic insufficiency (PI) were evaluated.MethodsPre- and post-menarcheal females with CF and PI (8-29 yr) were compared to healthy females. Z-scores for growth and body composition, anthropometry and DEXA were assessed. REE was measured in all subjects and pulmonary function in CF.ResultsCompared to healthy females (n=28, 14.6+/-4.1 yr), females with CF (n=16, 14.7+/-4.4 yr) had lower height Z (-0.1+/-0.9 versus -0.9+/-0.9, P=0.009) and muscle area Z (0.8+/-1.3 versus-0.4+/-1.2, P=0.007), and higher REE (100+/-10 versus 110+/-11% predicted, P=0.008). Difference in REE was more pronounced for post-menarcheal girls. REE adjusted for fat and fat-free mass was significantly higher with CF (+110 calories/day), and declined with menarcheal age in all subjects. FEV[1] was positively associated with BMI Z score, and negatively associated with age at menarche.ConclusionsHeight and muscle stores were reduced and REE elevated in subjects with CF compared to healthy controls. Poorer growth and nutritional status and delayed menarche were associated with poorer pulmonary function in CF and were likely related to the cumulative effect of energy imbalance on growth and body composition. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
16. Body-composition alterations consistent with cachexia in children and young adults with Crohn disease.
- Author
-
Burnham JM, Shults J, Semeao E, Foster BJ, Zemel BS, Stallings VA, and Leonard MB
- Abstract
BACKGROUND: Crohn disease (CD) in children is associated with low body mass index (BMI), poor growth, and delayed maturation; alterations in lean and fat mass, however, are poorly characterized. OBJECTIVE: The objective was to quantify lean and fat mass in children and young adults with CD and in healthy control subjects, relative to height and pubertal maturation. DESIGN: This cross-sectional study assessed whole-body lean and fat mass by using dual-energy X-ray absorptiometry in 104 subjects with CD and in 233 healthy control subjects aged 4-25 y. Linear regression was used to determine the effect of CD on body composition and to generate sex-specific SD scores (z scores) for lean and fat mass relative to height. RESULTS: Subjects with CD had lower height-for-age and BMI-for-age z scores (P < 0.001 for both) than did control subjects. CD was associated with significant deficits in lean mass after adjustment for height, age, race, and Tanner stage (P = 0.003); deficits in fat mass were not observed. The mean (+/-SD) lean mass-for-height and fat mass-for-height z scores in the subjects with CD were -0.61 +/- 0.92 and -0.04 +/- 0.86, respectively. Within the control group, fat mass-for-height was positively correlated with lean mass-for height (r = 0.41, P < 0.0001); this association was absent in the subjects with CD. CONCLUSIONS: Children and young adults with CD had significant deficits in lean mass but preserved fat mass, which is consistent with cachexia. Further research is needed to identify physical activity, nutritional, and antiinflammatory interventions to improve body composition in persons with CD. Copyright © 2005 American Society for Clinical Nutrition [ABSTRACT FROM AUTHOR]
- Published
- 2005
17. Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula.
- Author
-
Stettler N, Stallings VA, Troxel AB, Zhao J, Schinnar R, Nelson SE, Ziegler EE, and Strom BL
- Published
- 2005
18. Plasma zinc is an insensitive predictor of zinc status: use of plasma zinc in children with sickle cell disease.
- Author
-
Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, and Stallings VA
- Published
- 2002
- Full Text
- View/download PDF
19. Health status of children with moderate to severe cerebral palsy.
- Author
-
Liptak GS, O'Donnell M, Conaway M, Chumlea WC, Worley G, Henderson RC, Fung E, Stallings VA, Samson-Fang L, Calvert R, Rosenbaum P, Stevenson RD, Liptak, G S, O'Donnell, M, Conaway, M, Chumlea, W C, Wolrey, G, Henderson, R C, Fung, E, and Stallings, V A
- Published
- 2001
- Full Text
- View/download PDF
20. Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis.
- Author
-
Stettler N, Kawchak DA, Boyle LL, Propert KJ, Scanlin TF, Stallings VA, and Zemel BS
- Abstract
BACKGROUND: Several cross-sectional studies have shown improvement in the growth of children with cystic fibrosis (CF) because of increased awareness of and more comprehensive care of their special nutritional needs. However, longitudinal data on the nutritional status of these children are rare. OBJECTIVE: The objective was to compare changes in growth, body composition, and nutritional status between children with and without CF. DESIGN: This was a prospective 3-y cohort study of 25 children aged 5-10 y with CF, mild pulmonary disease, and pancreatic insufficiency and of 26 healthy control children. Three methods were used to assess body composition: measurements of skinfold thickness, total body water by deuterium oxide, and total-body electrical conductivity. Growth and body-composition changes over time were analyzed by a longitudinal mixed-effects model. RESULTS: Over the 3 y of the study, the statural growth of the boys with CF was slower than that of the control subjects (P = 0.004). The same divergence over time between the boys with and without CF was observed for fat-free mass assessed by skinfold-thickness measurements and total body water (P = 0.008 and 0.02, respectively) and for fat mass assessed by skinfold-thickness measurements and total-body electrical conductivity (P = 0.009 and 0.001, respectively). The differences in the pattern of changes in growth and body composition were less striking for girls. CONCLUSIONS: Despite comprehensive care, the growth of boys with CF was impaired on the basis of height, fat-free mass, and fat mass, when observed longitudinally. Caution should be used when interpreting cross-sectional measurements because they often do not detect suboptimal growth. Copyright © 2000 American Society for Clinical Nutrition [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
21. Early risk factors for increased adiposity: a cohort study of African American subjects followed from birth to young adulthood.
- Author
-
Stettler N, Tershakovec AM, Zemel BS, Leonard MB, Boston RC, Katz SH, and Stallings VA
- Abstract
BACKGROUND: Obesity is an increasing concern in the United States. Effective prevention of obesity requires the risk factors to be well defined. African Americans have a high risk of obesity. OBJECTIVE: The objective of this study was to identify risk factors, present at birth, for increased adiposity in adulthood in an African American population. DESIGN: In this retrospective analysis of a prospective cohort study, anthropometric and socioeconomic variables were collected at birth. A representative sample of 447 African American subjects was followed up until young adulthood, when skinfold thickness was measured. Associations between the independent variables and increased adiposity (skinfold thickness above the 85th percentile) were explored by using unadjusted and adjusted analyses. RESULTS: Three variables measured at birth were independently associated with adiposity in young adulthood, explaining 12% of the variance. The odds ratios (with 95% CIs) of these variables for increased adiposity were 2.7 (1.2, 6.2) for female sex, 4.0 (1.4, 11. 2) for first-born status, and 1.15 (1.06, 1.25) for each unit increment in maternal prepregnancy body mass index (BMI; in kg/m(2)). After adjustment for these variables, birth weight for gestational age and socioeconomic variables were not associated with adiposity. CONCLUSIONS: This cohort study of African American subjects was the first to identify first-born status as an independent risk factor for increased adiposity in adulthood in a US population. The results of the study strengthen previous reports of the effect of female sex and maternal BMI on adulthood obesity. Identification of risk factors early in life may help target prevention toward high-risk children and allow healthy lifestyles to be established before the onset of obesity. Copyright © 2000 American Society for Clinical Nutrition [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
22. Nutritional status and growth of children with diplegic or hemiplegic cerebral palsy.
- Author
-
Stallings VA, Charney EB, Davies JC, Cronk CE, Stallings, V A, Charney, E B, Davies, J C, and Cronk, C E
- Published
- 1993
- Full Text
- View/download PDF
23. Evaluation of methodology for nutritional assessment in children: anthropometry, body composition, and energy expenditure.
- Author
-
Zemel BS, Riley EM, and Stallings VA
- Abstract
Nutritional status in children is an indicator of health and well-being at both the individual and the population level. Screening for malnutrition should be an integral part of pediatric care universally. Nutritional intervention requires repeated measurement of nutritional status to assess severity and to track progress over time. Methodological issues in the assessment of nutritional status are reviewed with emphasis on anthropometric measurement, body composition, and energy expenditure of children at risk for malnutrition. Use of reference data, measurement error, maturational effects, and hereditary factors are among the issues reviewed and serve as guidelines in the interpretation of measurement of nutritional status. [ABSTRACT FROM AUTHOR]
- Published
- 1997
- Full Text
- View/download PDF
24. Reduction of elevated LDL-cholesterol levels of 4- to 10-year-old children through home-based dietary education.
- Author
-
Shannon BM, Tershakovec AM, Martel JK, Achterberg CL, Cortner JA, Smiciklas-Wright HS, Stallings VA, and Stolley PD
- Published
- 1994
- Full Text
- View/download PDF
25. NIH conference: supplements in children part 2. Treatment of childhood disease and prevention of childhood and adult disease.
- Author
-
Stallings VA
- Abstract
There are many examples of safe and efficacious supplement use in pediatric care, mostly the use of vitamins, minerals, protein, carbohydrate, and fat in specific clinical and diagnostic settings. The available scientific literature does not support the use of herbal and botanical compounds for common acute or chronic pediatric conditions. In health promotion and disease prevention, with few exceptions, there are no data to evaluate the safety and efficacy of supplements in preventing childhood disease. There is no literature to support supplement use in childhood to prevent adult disease, and this would require very long observation periods to establish efficacy. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
26. One-year follow-up of weight, total body potassium, and total body nitrogen in obese adolescents treated with the protein-sparing modified fast
- Author
-
Stallings, VA, primary, Archibald, EH, additional, Pencharz, PB, additional, Harrison, JE, additional, and Bell, LE, additional
- Published
- 1988
- Full Text
- View/download PDF
27. Potassium, magnesium, and calcium balance in obese adolescents on a protein-sparing modified fast
- Author
-
Stallings, VA, primary, Archibald, EH, additional, and Pencharz, PB, additional
- Published
- 1988
- Full Text
- View/download PDF
28. Parental feeding attitudes and styles and child body mass index prospective analysis of a gene-environment interaction.
- Author
-
Faith MS, Berkowitz RI, Stallings VA, Kerns J, Storey M, and Stunkard AJ
- Published
- 2004
- Full Text
- View/download PDF
29. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy.
- Author
-
Henderson RC, Lark RK, Gurka MJ, Worley G, Fung EB, Conaway M, Stallings VA, and Stevenson RD
- Published
- 2002
- Full Text
- View/download PDF
30. Feeding dysfunction is associated with poor growth and health status in children with cerebral palsy.
- Author
-
Fung EB, Samson-Fang L, Stallings VA, Conaway M, Liptak G, Henderson RC, Worley G, O'Donnell M, Calvert R, Rosenbaum P, Chumlea W, and Stevenson RD
- Published
- 2002
- Full Text
- View/download PDF
31. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
- Author
-
Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA, Leonard, Mary B, Feldman, Harold I, Shults, Justine, Zemel, Babette S, Foster, Bethany J, and Stallings, Virginia A
- Abstract
Background: Glucocorticoids suppress bone formation, impair growth, and induce obesity. We determined the effects of long-term treatment with glucocorticoids on bone mineral content in children with glucocorticoid-sensitive nephrotic syndrome, a disorder with minimal known independent effects on bone.Methods: We performed dual-energy x-ray absorptiometry of the whole body and spine in 60 children and adolescents with the nephrotic syndrome and 195 control subjects. We used linear regression analysis of log-transformed values to compare the bone mineral content in patients with that in controls.Results: Patients had received an average of 23,000 mg of glucocorticoids and were shorter (P=0.008) and had a greater body-mass index (P<0.001) than controls. The bone mineral content of the spine, adjusted for bone area, age, sex, degree of maturation (Tanner stage), and race, did not differ significantly between patients and controls (ratio, 0.99; 95 percent confidence interval, 0.96 to 1.02; P=0.51). After adjustment for the z score for body-mass index, the bone mineral content of the spine was significantly lower in patients than in controls (0.96; 95 percent confidence interval, 0.92 to 0.99; P=0.01). Whole-body bone mineral content, adjusted for height, age, sex, degree of maturation, and race, was significantly higher in patients than in controls (ratio, 1.11; 95 percent confidence interval, 1.05 to 1.18; P<0.001); however, the addition of the z score for body-mass index to the model eliminated the association with the nephrotic syndrome (ratio, 0.99; 95 percent confidence interval, 0.94 to 1.03; P=0.55).Conclusions: Intermittent treatment with high-dose glucocorticoids during growth does not appear to be associated with deficits in the bone mineral content of the spine or whole body relative to age, bone size, sex, and degree of maturation. Glucocorticoid-induced increases in body-mass index were associated with increased whole-body bone mineral content and maintenance of the bone mineral content of the spine. [ABSTRACT FROM AUTHOR]- Published
- 2004
32. Impact of acute illness on nutritional status of infants and young children with sickle cell disease.
- Author
-
Malinauskas BM, Gropper SS, Kawchak DA, Zemel BS, Ohene-Frempong K, and Stallings VA
- Published
- 2000
- Full Text
- View/download PDF
33. Research and professional briefs. Longitudinal analysis shows serum carotenoid concentrations are low in children with cystic fibrosis.
- Author
-
Kawchak DA, Sowell AL, Hofley PM, Zemel BS, Scanlin TF, and Stallings VA
- Published
- 1999
- Full Text
- View/download PDF
34. Impact of lumacaftor/ivacaftor on nutrition and growth in modulator-naïve children over 24 weeks.
- Author
-
Tindall A, Bass R, Maqbool A, and Stallings VA
- Subjects
- Humans, Male, Child, Preschool, Female, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Canada, Bile Acids and Salts metabolism, Bile Acids and Salts blood, Fatty Acids metabolism, Leukocyte L1 Antigen Complex analysis, Child Development drug effects, Cystic Fibrosis drug therapy, Cystic Fibrosis metabolism, Cystic Fibrosis physiopathology, Quinolones, Aminophenols, Benzodioxoles, Drug Combinations, Aminopyridines, Chloride Channel Agonists therapeutic use, Nutritional Status drug effects
- Abstract
Background: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators improve nutritional status and are of importance in achieving normal growth among younger children with CF. The study was designed to examine CFTR modulator-associated changes in nutrition status, including bile acids and fatty acids after lumacaftor/ivacaftor therapy for 24 weeks., Methods: Children 2 to 5.9 years were recruited from US and Canadian CF Centers. Eligible children were lumacaftor/ivacaftor naïve and approved to initiate therapy. Anthropometrics, diet, energy expenditure, nutrition biomarkers, pancreatic status, serum and fecal calprotectin, serum bile acids and plasma fatty acids were measured. Changes from baseline at 12 and 24 weeks were examined using mixed effects linear regression modeling., Results: Weight-for-age z-score (WAZ) increased at 12 (0.15 ± 0.1, p = 0.01) and 24 weeks (0.23 ± 0.1, p = 0.001) from baseline following modulator therapy. Head circumference-for-age (HCZ) increased at 12 weeks compared to baseline (0.22 ± 0.1, p = 0.03) and subscapular Z score increased from baseline at 24 weeks following therapy (0.33 ± 0.1, p = 0.02). There were no changes in energy expenditure. Serum total bile acids (6.7 ± 2.0, p = 0.001), chenodeoxycholic acid (CDCA) (2.4 ± 1.1, p = 0.001), and cholic acid (CA) (3.5 ± 0.8, p < 0.0001) increased at 24 weeks compared to baseline. Fecal calprotectin decreased at 12 and 24 weeks compared to baseline (-463 ± 310, p = 0.03 and 566 ± 347, p = 0.047). A number of plasma fatty acids changed over the course of 24 weeks of therapy. Noteably, alpha-linolenic acid (ALA) decreased at 12 and 24 weeks (-24 ± 10,p = 0.03 and -18 ± 10, p = 0.02, respectively)., Conclusions: Overall, young children experienced favorable changes in nutritional and growth, with the exception of plasma ALA status in the first 24 weeks of lumacaftor/ivacaftor therapy., Competing Interests: Declaration of competing interest All authors disclose they have no conflicts of interest related to this project and manuscript. The funding sources had no role in study design, analysis or drafting of the manuscript., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
35. Environmental phenol exposures in 6- to 12-week-old infants: The Infant Feeding and Early Development (IFED) study.
- Author
-
Goldberg M, Adgent MA, Stevens DR, Chin HB, Ferguson KK, Calafat AM, Travlos G, Ford EG, Stallings VA, Rogan WJ, Umbach DM, Baird DD, and Sandler DP
- Subjects
- Humans, Infant, Female, Male, Prospective Studies, Environmental Pollutants urine, Endocrine Disruptors urine, Endocrine Disruptors analysis, Adult, Phenols urine, Environmental Exposure analysis
- Abstract
Background: Exposure to phenols, endocrine-disrupting chemicals used in personal care and consumer products, is widespread. Data on infant exposures are limited despite heightened sensitivity to endocrine disruption during this developmental period. We aimed to describe distributions and predictors of urinary phenol concentrations among U.S. infants ages 6-12 weeks., Methods: The Infant Feeding and Early Development (IFED) study is a prospective cohort study of healthy term infants enrolled during 2010-2013 in the Philadelphia region. We measured concentrations of seven phenols in 352 urine samples collected during the 6- or 8- and/or 12-week study visits from 199 infants. We used linear mixed models to estimate associations of maternal, sociodemographic, infant, and sample characteristics with natural-log transformed, creatinine-standardized phenol concentrations and present results as mean percent change from the reference level., Results: Median concentrations (μg/L) were 311 for methylparaben, 10.3 for propylparaben, 3.6 for benzophenone-3, 2.1 for triclosan, 1.0 for 2,5-dichlorophenol, 0.7 for BPA, and 0.3 for 2,4-dichlorophenol. Geometric mean methylparaben concentrations were approximately 10 times higher than published estimates for U.S. children ages 3-5 and 6-11 years, while propylparaben concentrations were 3-4 times higher. Infants of Black mothers had higher concentrations of BPA (83%), methylparaben (121%), propylparaben (218%), and 2,5-dichorophenol (287%) and lower concentrations of benzophenone-3 (-77%) and triclosan (-53%) than infants of White mothers. Triclosan concentrations were higher in breastfed infants (176%) and lower in infants whose mothers had a high school education or less (-62%). Phenol concentrations were generally higher in summer samples., Conclusions: Widespread exposure to select environmental phenols among this cohort of healthy U.S. infants, including much higher paraben concentrations compared to those reported for U.S. children, supports the importance of expanding population-based biomonitoring programs to infants and toddlers. Future investigation of exposure sources is warranted to identify opportunities to minimize exposures during these sensitive periods of development., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Co-author serves as an Associate Editor for this journal - K.K.F. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
36. A comparison of ultrasound-based testis volume with Prader orchidometry and stability of testis size relative to peers from birth to 28 weeks.
- Author
-
Chin HB, Amabile TH, Kelly A, Patchel SA, Darge K, Kaplan SL, Ford EG, Stallings VA, Rogan WJ, and Umbach DM
- Abstract
Background: Testis volume, an indicator of the reproductive development during minipuberty, is commonly measured by Prader orchidometer, despite ultrasound being the gold standard. Data are lacking on the longitudinal relationship between these two measures and on the stability of boys' relative testis size across infancy., Objectives: To examine the relationship between ultrasound-based and orchidometer-based testis volume measurements and to assess the stability of relative testis size among individual boys in the study., Materials and Methods: The Infant Feeding and Early Development study is a longitudinal cohort of healthy infants recruited from hospitals in the Philadelphia area during 2010-2013. We measured testis size from birth to 28 weeks in 147 infants using Prader orchidometry (nine study visits) and ultrasound (five study visits). We modeled testis growth, extracted predicted volumes for each boy on each day of the study, and ranked these volumes from smallest to largest., Results: The average testis volume trajectory exhibited linear growth over the first 16 weeks followed by slower growth and then a plateau. Prader orchidometry overestimated testis size by almost 3-fold, compared to ultrasound. A range of ultrasound volumes corresponded to each bead size (e.g., bead size of 1 cm
3 corresponded to an ultrasound-based volume between 0.11 and 0.87 cm3 ). Infants changed rankings of median of 22 positions (of 147) across the entire 6-month follow-up. Infants' ranks near birth were highly correlated with their ranks at the end of the study., Discussion: Consistent with other studies, we found wide variability in testis size during infancy and that Prader orchidometry overestimates testis size. When compared to ultrasound, orchidometry only crudely estimates testis size in this age group. Ultrasound-based volumes generally showed stability in relative testis size across infancy., Conclusion: Accurate measurement of testis size is difficult using orchidometry in infants. This highlights the need for ultrasound for accurate measurement, with a one-time measurement likely sufficient to determine relative testis size across the first 6 months of infancy., (© 2024 American Society of Andrology and European Academy of Andrology.)- Published
- 2024
- Full Text
- View/download PDF
37. Environmental Phenols and Growth in Infancy: The Infant Feeding and Early Development Study.
- Author
-
Stevens DR, Goldberg M, Adgent M, Chin HB, Baird DD, Stallings VA, Sandler DP, Calafat AM, Ford EG, Zemel BS, Kelly A, Umbach DM, Rogan W, and Ferguson KK
- Abstract
Context: Higher mean and rapid increases in body mass index (BMI) during infancy are associated with subsequent obesity and may be influenced by exposure to endocrine-disrupting chemicals such as phenols., Objective: In a prospective US-based cohort conducted 2010-2014, we investigated associations between environmental phenol exposures and BMI in 199 infants., Methods: We measured seven urinary phenols at ages 6-8 and 12 weeks and assessed BMI z-score at up to 12 study visits between birth and 36 weeks. We examined individual and joint associations of averaged early infancy phenols with level of BMI z-score using mean differences (β [95% confidence intervals (CI)]) and with BMI z-score trajectories using relative risk ratios (RR [95% CI])., Results: Benzophenone-3, methyl and propyl paraben, and all phenols jointly were positively associated with higher mean BMI z-score (0.07 [-0.05, 0.18], 0.10 [-0.08, 0.27], 0.08 [-0.09, 0.25], 0.17 [-0.08, 0.43], respectively). Relative to a Stable trajectory, benzophenone-3, 2,4-dichlorophenol, 2,5-dichlorophenol, and all phenols jointly were positively associated with risk of a Rapid Increase trajectory (1.46 [0.89, 2.39], 1.33 [0.88, 2.01], 1.66 [1.03, 2.68], 1.41 [0.71, 2.84], respectively)., Conclusion: Early phenol exposure was associated with a higher mean and rapid increase in BMI z-score across infancy, signaling potential long-term cardiometabolic consequences of exposure., (Published by Oxford University Press on behalf of the Endocrine Society 2024.)
- Published
- 2024
- Full Text
- View/download PDF
38. Changes in fecal lipidome after treatment with ivacaftor without changes in microbiome or bile acids.
- Author
-
Bass R, Tanes C, Bittinger K, Li Y, Lee H, Friedman ES, Koo I, Patterson AD, Liu Q, Wu GD, and Stallings VA
- Subjects
- Humans, Male, Female, Adult, Adolescent, Child, Middle Aged, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Young Adult, Cystic Fibrosis microbiology, Cystic Fibrosis drug therapy, Aminophenols therapeutic use, Feces microbiology, Feces chemistry, Quinolones therapeutic use, Bile Acids and Salts analysis, Bile Acids and Salts metabolism, Chloride Channel Agonists therapeutic use, Gastrointestinal Microbiome drug effects, Lipidomics methods
- Abstract
Background: Alterations in gastrointestinal health are prominent manifestations of cystic fibrosis (CF) and can independently impact pulmonary function. Ivacaftor has been associated with robust improvements in pulmonary function and weight gain, but less is known about the impact of ivacaftor on the fecal microbiome, lipidome, and bile acids., Methods: Stool samples from 18 patients with CF and gating mutations (ages 6-61 years, 13 pancreatic insufficient) were analyzed for fecal microbiome and lipidome composition as well as bile acid concentrations at baseline and after 3 months of treatment with ivacaftor. Microbiome composition was also assessed in a healthy reference cohort., Results: Alpha and beta diversity of the microbiome were different between CF and reference cohort at baseline, but no treatment effect was seen in the CF cohort between baseline and 3 months. Seven lipids increased with treatment. No differences were seen in bile acid concentrations after treatment in CF. At baseline, 403 lipids and unconjugated bile acids were different between pancreatic insufficient (PI-CF) and sufficient (PS-CF) groups and 107 lipids were different between PI-CF and PS-CF after 3 months of treatment., Conclusions: The composition and diversity of the fecal microbiome were different in CF as compared to a healthy reference, and did not change after 3 months of ivacaftor. We detected modest differences in the fecal lipidome with treatment. Differences in lipid and bile acid profiles between PS-CF and PI-CF were attenuated after 3 months of treatment., Competing Interests: Declaration of Competing Interest None., (Copyright © 2023. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
39. Impact of maternal depression on malnutrition treatment outcomes in older children with sickle cell anemia.
- Author
-
Ritter C, Abdullahi SU, Gambo S, Murtala HA, Kabir H, Shamsu KA, Gwarzo G, Banaei Y, Acra SA, Stallings VA, Rodeghier M, DeBaun MR, and Klein LJ
- Abstract
Background: Malnutrition and sickle cell anemia (SCA) result in high childhood mortality rates. Although maternal depression is an established risk factor for malnutrition in younger children, little is known about its impact on treatment response in children with malnutrition. We aimed to determine the relationship, if any, between maternal depression scores and malnutrition treatment outcomes in older children with SCA., Methods: We conducted a planned ancillary study to our randomized controlled feasibility trial for managing severe acute malnutrition in children aged 5-12 with SCA in northern Nigeria (NCT03634488). Mothers of participants completed a depression screen using the Patient Health Questionnaire (PHQ-9).We used a multivariable linear regression model to describe the relationship between the baseline maternal PHQ-9 score and the trial participant's final body mass index (BMI) z-score., Results: Out of 108 mother-child dyads, 101 with maternal baseline PHQ-9 scores were eligible for inclusion in this analysis. At baseline, 25.7% of mothers (26 of 101) screened positive for at least mild depression (PHQ-9 score of 5 or above). The baseline maternal PHQ-9 score was negatively associated with the child's BMI z-score after 12 weeks of malnutrition treatment (β=-0.045, p = 0.041)., Conclusions: Maternal depressive symptoms has an impact on malnutrition treatment outcomes. Treatment of malnutrition in older children with sickle cell anemia should include screening for maternal depression and, if indicated, appropriate maternal referral for depression evaluation and treatment., Trial Registration: The trial was registered at clinicaltrials.gov (#NCT03634488) on January 30, 2018, https://clinicaltrials.gov/study/NCT03634488 ., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
40. Association of Diet Patterns and Post-Operative Tympanostomy Tube Otorrhea: A Pilot Study.
- Author
-
Dedhia K, Li Y, Stallings VA, Germiller J, Giordano T, Dailey J, Kong M, Durkin A, Legg-Jack I, Nessen S, and Schapira MM
- Subjects
- Child, Humans, Infant, Infant, Newborn, Child, Preschool, Pilot Projects, Middle Ear Ventilation adverse effects, Retrospective Studies, Cross-Sectional Studies, Diet, Otitis Media with Effusion etiology, Otitis Media with Effusion surgery
- Abstract
Objective: The objective of this study was to explore diet patterns in children with tympanostomy tube placement (TTP) complicated by postoperative tympanostomy tube otorrhea., Study Design: Cross-sectional survey and retrospective cohort study., Methods: Caregivers of children (0-12 years old), at a tertiary-care pediatric hospital who underwent TTP within 6 months to 2 years prior to enrollment were included. Children with a history of Down syndrome, cleft palate, craniofacial syndromes, known immunodeficiency, or a non-English-speaking family were excluded. Our primary outcome variable was the number of otorrhea episodes. The primary predictor was diet patterns, particularly dessert intake, which was captured through a short food questionnaire., Results: A total of 286 participants were included in this study. The median age was 1.8 years (IQR, 1.3, 2.9). A total of 174 (61%) participants reported at least one episode of otorrhea. Children who consumed dessert at least two times per week had a higher risk of otorrhea compared to children who consumed one time per week or less (odds ratio [OR], 3.22, 95% Confidence Interval [CI]: 1.69, 6.12). The odds ratio increase continued when considering more stringent criteria for otorrhea (multiple episodes or one episode occurring 4 weeks after surgery), with a 2.33 (95% CI: 1.24, 4.39) higher odds of otorrhea in children with dessert intake at least 2 times per week., Conclusions: Our pilot data suggest that episodes of otorrhea among children with TTP were associated with more frequent dessert intake. Future studies using prospectively administered diet questionnaires are necessary to confirm these findings., Level of Evidence: 4 Laryngoscope, 133:3575-3581, 2023., (© 2023 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2023
- Full Text
- View/download PDF
41. Glutamic acid intake by formula-fed infants: are acceptable daily intakes appropriate?
- Author
-
Mennella JA, Smethers AD, Delahanty MT, Stallings VA, and Trabulsi JC
- Subjects
- Infant, Female, Animals, Cattle, Child, Humans, Prospective Studies, No-Observed-Adverse-Effect Level, Milk, Protein Hydrolysates, Infant Nutritional Physiological Phenomena, Glutamic Acid, Infant Formula
- Abstract
The 2017 European Food Safety Authority (EFSA) recommendation of an acceptable daily intake (ADI) of 30 mg glutamic acid/kg bw/day did not take into consideration the primary energy sources during infancy, including infant formulas. In the present study, we determined total daily intakes of glutamic acid in a contemporary cohort of healthy infants who were fed either cow milk formula (CMF) or extensive protein hydrolysate formula (EHF); the formulas differed substantially in glutamic acid content. The infants (n = 141) were randomized to be fed either CMF or EHF. Dietary intakes were determined from weighed bottle methods and/or prospective diet records, and body weights were measured on 14 occasions from 0.5 to 12.5 months. Secondary data analysis determined the glutamic acid content of the diet over time. The trial was registered at http://www., Clinicaltrials: gov/ as NCT01700205, 3 October 2012. Glutamic acid intake from formula and other foods was significantly higher in infants fed EHF when compared to CMF. As glutamic acid intake from formula decreased, intake from other nutritional sources steadily increased from 5.5 months. Regardless of formula type, every infant exceeded the ADI of 30 mg/kg bw/day from 0.5 to 12.5 months. Conclusion: Given that the ADI recommendation was not based on actual intake data of primary energy sources during infancy, the present findings on the growing child's ingestion of glutamic acid from infant formula and the complementary diet may be of interest when developing future guidelines and communications to parents, clinical care providers, and policy makers., What Is Known: • The 2017 re-evaluation of the safety of glutamic acid-glutamates and the recommended acceptable daily intake (ADI) of 30 mg/kg bw/d by the European Food Safety Authority (EFSA) did not include actual intake data of the primary energy sources during infancy., What Is New: • During the first year, glutamic acid intake from infant formula and other food sources exceeded the ADI of 30 mg/kg bw/day., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
42. Risk factors in underweight older children with sickle cell anemia: a comparison of low- to high-income countries.
- Author
-
Klein LJ, Abdullahi SU, Gambo S, Stallings VA, Acra S, Rodeghier M, and DeBaun MR
- Subjects
- Adolescent, Child, Humans, Cross-Sectional Studies, Developed Countries, Hemoglobins, Risk Factors, Anemia, Sickle Cell complications, Anemia, Sickle Cell epidemiology, Thinness complications, Thinness epidemiology
- Abstract
Previously, we demonstrated that older children with sickle cell anemia (SCA) living in Nigeria are at increased risk of death if they are underweight (weight-for-age z score < -1). We now conducted a cross-sectional study in low- and high-income settings to determine the risk factors for being underweight a in children aged 5 to 12 years with SCA. The children from low- and high-income settings were eligible participants for the Primary Prevention of Stroke in Children with Sickle Cell Disease in Nigeria (SPRING; N = 928) and the Silent Cerebral Infarct (SIT, North America/Europe; N = 1093) trials, respectively. The median age in the SPRING and SIT cohorts was 8.1 and 8.5 years, respectively (P < .001). A total of 87.9% (n = 816) of participants in the SPRING trial (low-income) met the study criteria for being underweight (weight-for-age z score < -1), and 22.7% (n = 211) for severely underweight (weight-for-age z score < -3), significantly higher than the SIT (high-income) cohort at 25.7% underweight (n = 281) and 0.7% severely underweight (n = 8; P < .001 for both comparisons). In the combined cohort, older age (odds ratio [OR], 1.24; P < .001) and lower hemoglobin level (OR, 0.67; P < .001) were associated with being underweight. Age and hemoglobin level remained statistically significant in separate models for the SPRING and SIT cohorts. Older age and lower hemoglobin levels in children aged 5 to 12 years with SCA are associated with being underweight in low- and high-income settings., (© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
43. Corrigendum to 'Lysophosphatidylcholine-Rich Nutrition Therapy Increased Gut Absorption of Coingested Dietary Fat: a Randomized Controlled Trial' [Curr Dev Nutr. 2023 Sep; 7(9): 101985].
- Author
-
Tindall A, Mascarenhas M, Maqbool A, and Stallings VA
- Abstract
[This corrects the article DOI: 10.1016/j.cdnut.2023.101985.]., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
44. Changes in nutrition and growth status in young children in the first 12 weeks of ivacaftor therapy.
- Author
-
Tindall A, Bass R, Maqbool A, and Stallings VA
- Subjects
- Humans, Male, Child, Child, Preschool, Infant, Female, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Cystic Fibrosis Transmembrane Conductance Regulator metabolism, Nutritional Status, Mutation, Canada epidemiology, Aminophenols therapeutic use, Fatty Acids, Bile Acids and Salts, Cystic Fibrosis drug therapy, Cystic Fibrosis metabolism
- Abstract
Background: Highly effective CFTR modulators improve nutritional status and are of particular importance among younger children experiencing rapid growth. This study was designed to examine CFTR modulator associated changes in nutritional and other extrapulmonary outcomes in children 4-24 months of age with ivacaftor treatment over 12 weeks., Methods: Children 4-24 months were recruited from US and Canadian CF Centers. Eligible children were ivacaftor naïve and approved to start therapy. Anthropometrics, diet, sleeping energy expenditure (SEE), nutrition biomarkers, pancreatic status, serum and fecal calprotectin, serum bile acids, plasma fatty acids were measured. Changes from baseline at 6 and 12 weeks were examined using mixed effects linear regression modeling., Results: Fifteen participants enrolled (40% male). Weight-for-age z-scores increased at 6 (p = 0.03) and 12 weeks ivacaftor therapy (p<0.001) compared to baseline. Plasma docosatetraenoic acid (DTA), total saturated fatty acids increased at 6 weeks (p = 0.02) and 12 weeks (p = 0.009). At 12 weeks, serum CO
2 concentration decreased (p = 0.002), serum urea nitrogen increased (p = 0.01) and fecal elastase increased (p = 0.02) compared to baseline. Bile acids, deoxycholic acid increased (p = 0.03) and ursodeoxycholic acid decreased (p = 0.02) after 12 weeks. Plasma total fatty acids, palmitic acid, mead, and docosatetraenoic acid (DTA) increased after 12 weeks (p = 0.02, p = 0.002 and p = 0.04, respectively). Plasma total saturated fatty acids increased at 6 weeks (p = 0.02) and 12 weeks (p = 0.009). Dietary intake (p = 0.04) and percent kcal from protein (p = 0.04) increased after 12 weeks compared to baseline., Conclusions: Overall, younger children experienced favorable changes in nutritional and growth status in the first 12 weeks of ivacaftor therapy., Competing Interests: Declaration of Competing Interest All authors disclose they have no conflicts of interest related to this project and manuscript. The funding sources had no role in study design, analysis or drafting of the manuscript., (Copyright © 2023. Published by Elsevier B.V.)- Published
- 2023
- Full Text
- View/download PDF
45. Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria.
- Author
-
Abdullahi SU, Gambo S, Murtala HA, Kabir H, Shamsu KA, Gwarzo G, Acra S, Stallings VA, Rodeghier M, DeBaun MR, and Klein LJ
- Subjects
- Humans, Child, Nigeria epidemiology, Hydroxyurea adverse effects, Feasibility Studies, Severe Acute Malnutrition complications, Malnutrition etiology, Anemia, Sickle Cell complications, Anemia, Sickle Cell drug therapy
- Abstract
Children with sickle cell anemia (SCA) living in Nigeria are at an increased risk of malnutrition, which contributes to increased morbidity and mortality. However, evidence-based guidelines for managing malnutrition in children with SCA are lacking. To address this gap, we conducted a multicenter, randomized controlled feasibility trial to assess the feasibility and safety of treating children with SCA aged from 5 to 12 years and having uncomplicated severe acute malnutrition (body mass index z score of <-3.0). Children with SCA and uncomplicated severe acute malnutrition were randomly allocated to receive supplemental ready-to-use therapeutic food (RUTF) with or without moderate-dose hydroxyurea therapy (20 mg/kg per day). Over a 6-month enrollment period, 3190 children aged from 5 to 12 years with SCA were evaluated for eligibility, and 110 of 111 children who were eligible were enrolled. During the 12-week trial, no participants withdrew or missed visits. One participant died of unrelated causes. Adherence was high for hydroxyurea (94%, based on pill counts) and RUTF (100%, based on the number of empty sachets returned). No refeeding syndrome event or hydroxyurea-related myelosuppression occurred. At the end of the trial, the mean change in body mass index z score was 0.49 (standard deviation = 0.53), and 39% of participants improved their body mass index z score to ≥-3.0. Our findings demonstrate the feasibility, safety, and potential of outpatient treatment for uncomplicated severe acute malnutrition in children with SCA aged from 5 to 12 years in a low-resource setting. However, RUTF sharing with household and community members potentially confounded the response to malnutrition treatment. This trial was registered at clinicaltrials.gov as #NCT03634488., (© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
46. Use of Compartmental Modeling and Retinol Isotope Dilution to Determine Vitamin A Stores in Young People with Sickle Cell Disease Before and After Vitamin A Supplementation.
- Author
-
Ford JL, Green MH, Brownell JN, Green JB, Oxley A, Lietz G, Schall JI, and Stallings VA
- Subjects
- Child, Humans, Adolescent, Vitamin A, Dietary Supplements, Isotopes, Vitamin A Deficiency, Anemia, Sickle Cell
- Abstract
Background: Suboptimal plasma retinol concentrations have been documented in US children with sickle cell disease (SCD) hemoglobin SS type (SCD-HbSS), but little is known about vitamin A kinetics and stores in SCD., Objectives: The objectives were to quantify vitamin A total body stores (TBS) and whole-body retinol kinetics in young people with SCD-HbSS and use retinol isotope dilution (RID) to predict TBS in SCD-HbSS and healthy peers as well as after vitamin A supplementation in SCD-HbSS subjects., Methods: Composite plasma [
13 C10 ]retinol response data collected from 22 subjects with SCD-HbSS for 28 d after isotope ingestion were analyzed using population-based compartmental modeling ("super-subject" approach); TBS and retinol kinetics were quantified for the group. TBS was also calculated for the same individuals using RID, as well as for healthy peers (n = 20) and for the subjects with SCD-HbSS after 8 wk of daily vitamin A supplements (3.15 or 6.29 μmol retinol/d [900 or 1800 μg retinol activity equivalents/d])., Results: Model-predicted group mean TBS for subjects with SCD-HbSS was 428 μmol, equivalent to ∼11 mo of stored vitamin A; vitamin A disposal rate was 1.3 μmol/d. Model-predicted TBS was similar to that predicted by RID at 3 d postdosing (mean, 389 μmol; ∼0.3 μmol/g liver); TBS predictions at 3 compared with 28 d were not significantly different. Mean TBS in healthy peers was similar (406 μmol). RID-predicted TBS for subjects with SCD-HbSS was not significantly affected by vitamin A supplementation at either dose., Conclusions: Despite differences in plasma retinol concentrations, TBS was the same in subjects with SCD-HbSS compared with healthy peers. Because 56 d of vitamin A supplementation at levels 1.2 to 2.6 times the Recommended Dietary Allowance did not increase TBS in these subjects with SCD-HbSS, further work will be needed to understand the effects of SCD on retinol metabolism. This trial was registered as NCT03632876 at clinicaltrials.gov., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
47. Lysophosphatidylcholine-Rich Nutrition Therapy Increased Gut Absorption of Coingested Dietary Fat: a Randomized Controlled Trial.
- Author
-
Tindall A, Mascarenhas M, Maqbool A, and Stallings VA
- Abstract
Unintentional weight loss is common in persons with chronic and acute disease and is often caused by insufficient intake or malabsorption. A new lysophosphatidylcholine (LPC)-rich structured lipid powder has micelle-like activity that facilitates digestion and absorption, independent of lipase and bile acids. The aim of this secondary analysis was to determine if recycled LPC increased fat absorption of coingested food. Fasting plasma fatty acid (FA) concentrations were measured at baseline and 3 mo in children ( n = 84) with cystic fibrosis and pancreatic insufficiency. Plasma palmitic acid was selected because of its dietary prevalence and was a minor component of the LPC product. Palmitic acid increased 15% in the LPC product-treated total subjects ( P = 0.01) and 23% in the subgroup with more severe malabsorption ( P = 0.007), with no change in either group on placebo. Total FAs increased 11% ( P = 0.009) and 20% ( P = 0.005), respectively. Increased palmitic acid and total FA suggest that LPC provided by the product created an intraluminal environment that increased coingested dietary fat absorption and provided more calories. This trial was registered at clinicaltrials.gov as NCT00406536., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
48. Early Life Anti-Müllerian Hormone Trajectories in Infant Girls.
- Author
-
Chin HB, Krall JR, Goldberg M, Stanczyk FZ, Darge K, Stallings VA, Rogan WJ, Umbach DM, and Baird DD
- Subjects
- Female, Infant, Humans, Longitudinal Studies, Ovary, Estradiol, Anti-Mullerian Hormone, Follicle Stimulating Hormone
- Abstract
Background: Minipuberty is a period of increased reproductive axis activity in infancy, but the importance of this period is not well understood, especially in girls. Previous studies reported a peak in hormone concentrations at 3 to 4 months old. Our objective is to describe anti-Müllerian hormone (AMH) trajectories in the context of other minipuberty factors among healthy infant girls using longitudinal measures of AMH., Methods: The Infant Feeding and Early Development study is a longitudinal cohort study of healthy infants, recruited from hospitals in the Philadelphia area during 2010 to 2013. We measured AMH in 153 girls who contributed 1366 serum samples across 11 study visits over 36 weeks. We also measured follicle stimulating hormone (FSH), estradiol, and ovarian characteristics. We used latent class mixed effects models to cluster trajectories of AMH concentration with age. Using linear mixed models, we estimated FSH and ovarian characteristic trajectories separately by AMH cluster., Results: We classified infants into four clusters that represent patterns of AMH that were high and decreasing (decreasing), had a peak around 12 weeks or 20 weeks (early peak and middle peak), or were consistently low (low). Infants in these clusters differed in their FSH trajectories, timing of estradiol production, and ovarian characteristics., Conclusions: The AMH clusters identified suggest variation in the timing and the magnitude of the minipuberty response in infant girls. The decreasing and low clusters have not been described previously and should be further evaluated to determine whether they represent an opportunity for the early identification of later reproductive conditions., Competing Interests: The authors report no conflicts of interest., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
49. Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting.
- Author
-
Klein LJ, Abdullahi SU, Gambo S, Stallings VA, Acra S, Rodeghier M, and DeBaun MR
- Subjects
- Humans, Child, Child, Preschool, Hydroxyurea therapeutic use, Body Mass Index, Growth Disorders complications, Anemia, Sickle Cell complications, Anemia, Sickle Cell drug therapy, Stroke etiology
- Abstract
Undernutrition is a risk factor for under-5 mortality and is also postulated to be a risk factor for mortality in older children and adults with sickle cell anemia (SCA). We tested the hypothesis that underweight is associated with mortality in children aged 5 to 12 years with SCA. We performed a secondary analysis of participants in the Primary Prevention of Stroke in Children with Sickle Cell Disease in Nigeria trial, a double-blind, parallel-group randomized controlled trial for low-dose or moderate-dose hydroxyurea in children with abnormal transcranial Doppler velocities and a comparison group of participants with nonelevated transcranial Doppler velocities in northern Nigeria. Nutritional status was classified as underweight (weight-for-age z score), stunting (height-for-age z score), and wasting (body mass index z score) using the World Health Organization growth reference. The mean weight-for-age z score was lower in children who died during the study than in those who survived. Otherwise, the baseline characteristics of children who died during the study were not significantly different from those of the children who survived. A pooled analysis of participants demonstrated that a lower weight-for-age z score was associated with an increased hazard of death. Underweight participants (weight-for-age z score <-1) had a greater probability of death during follow-up than those who were not underweight. Underweight status in school-aged children with SCA is a previously unrecognized risk factor for early mortality in Nigeria and can be easily applied to screen children at risk for death. This trial was registered at www.clinicaltrials.gov as #NCT02560935., (© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
50. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
- Author
-
Putman MS, Norris AW, Hull RL, Rickels MR, Sussel L, Blackman SM, Chan CL, Ode KL, Daley T, Stecenko AA, Moran A, Helmick MJ, Cray S, Alvarez JA, Stallings VA, Tuggle KL, Clancy JP, Eggerman TL, Engelhardt JF, and Kelly A
- Subjects
- Adult, Adolescent, Male, Humans, Cystic Fibrosis Transmembrane Conductance Regulator genetics, Cystic Fibrosis Transmembrane Conductance Regulator metabolism, Research, Cystic Fibrosis complications, Cystic Fibrosis genetics, Cystic Fibrosis metabolism, Diabetes Mellitus etiology, Diabetes Mellitus genetics, Glucose Intolerance
- Abstract
Cystic fibrosis (CF) is a recessive disorder arising from mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein. CFTR is expressed in numerous tissues, with high expression in the airways, small and large intestine, pancreatic and hepatobiliary ducts, and male reproductive tract. CFTR loss in these tissues disrupts regulation of salt, bicarbonate, and water balance across their epithelia, resulting in a systemic disorder with progressive organ dysfunction and damage. Pancreatic exocrine damage ultimately manifests as pancreatic exocrine insufficiency that begins as early as infancy. Pancreatic remodeling accompanies this early damage, during which abnormal glucose tolerance can be observed in toddlers. With increasing age, however, insulin secretion defects progress such that CF-related diabetes (CFRD) occurs in 20% of teens and up to half of adults with CF. The relevance of CFRD is highlighted by its association with increased morbidity, mortality, and patient burden. While clinical research on CFRD has greatly assisted in the care of individuals with CFRD, key knowledge gaps on CFRD pathogenesis remain. Furthermore, the wide use of CFTR modulators to restore CFTR activity is changing the CFRD clinical landscape and the field's understanding of CFRD pathogenesis. For these reasons, the National Institute of Diabetes and Digestive and Kidney Diseases and the Cystic Fibrosis Foundation sponsored a CFRD Scientific Workshop, 23-25 June 2021, to define knowledge gaps and needed research areas. This article describes the findings from this workshop and plots a path for CFRD research that is needed over the next decade., (© 2023 by the American Diabetes Association.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.